A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team ...

The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...

V accine side effects like soreness, fever, and fatigue scare some people out of getting their shots. Ask a doctor, though, ...

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...

By restricting access to just one vaccine today, as has happened in the past through political wrangling, we risk repeating ...

The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...

Global vaccine production is operating at full capacity, but demand is outpacing supply, the UN health agency said in its ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...